Bellevue Group Ag Qiagen N.V. Transaction History
Bellevue Group Ag
- $4.31 Billion
- Q1 2025
Shares
13 transactions
Others Institutions Holding QGEN
# of Institutions
20Shares Held
5.57MCall Options Held
0Put Options Held
0-
Pendal Group LTD4.3MShares$182 Million1.76% of portfolio
-
Abeille Asset Management Sa931KShares$39.3 Million1.68% of portfolio
-
Pictet Asset Management Sa Geneva 73, V8153KShares$6.48 Million0.01% of portfolio
-
Bdl Capital Management Paris, I088.8KShares$3.75 Million3.33% of portfolio
-
Lapides Asset Management, LLC32KShares$1.35 Million0.97% of portfolio
About QIAGEN N.V.
- Ticker QGEN
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 227,694,000
- Market Cap $9.62B
- Description
- QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...